MedPath
NMPA Approval

Inclisiran Sodium Injection

国药准字HJ20230103

August 22, 2023

Drug Information

英克司兰钠注射液

乐可为

注射剂

1.5ml:284mg(按英克司兰计)

化学药品

August 22, 2023

August 21, 2028

Company Information

Applicant Company

Vista Building, Elm Park, Merrion Road, Dublin 4, Ireland

Manufacturing Company

Biochemiestrasse 10, 6336 Langkampfen, Austria

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

英克司兰钠注射液 - NMPA 批准文号 | MedPath